Company Filing History:
Years Active: 2022
Title: Armin Wolf: Innovator in Cancer Treatment
Introduction
Armin Wolf is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative work has led to the development of a unique combination of therapies aimed at improving patient outcomes.
Latest Patents
Armin Wolf holds a patent for "Combinations of FGFR4 inhibitors and bile acid sequestrants." This invention relates to a pharmaceutical combination that includes an FGFR4 inhibitor and a bile acid sequestrant. The patent outlines the use of this combination in the treatment of cancer and highlights the role of bile acid sequestrants in reducing or mitigating side effects associated with FGFR4 inhibition therapy.
Career Highlights
Armin Wolf is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key player in advancing cancer therapies.
Collaborations
Armin has collaborated with notable colleagues, including Robin Alec Fairhurst and Diana Graus Porta. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Armin Wolf's contributions to cancer treatment through his patented inventions and collaborations with esteemed colleagues underscore his importance in the pharmaceutical field. His work continues to pave the way for advancements in medical therapies.